Thanks, Sameer. Good morning, everyone. I hope you're all safe and well. On Chart 9, I'll cover the results and outlook of our Titanium Technologies segment. Titanium Technologies continues to experience improving pigment demand as the economic recovery gains speed. Ti-Pure demand across all end markets, product categories and geographies remained strong, a sign that the momentum from Q4 has carried into the first part of 2021. As you heard from Sameer, global logistics issues and Winter Storm Uri were both headwinds in the quarter. But our operations, supply chain and logistics teams have rallied in their support of our customers. We have prioritized product availability for our long-term AVA contract customers, consistent with our TVS strategy. I am very proud of our ability to deliver high-quality Ti-Pure pigment around the world at a time when some of our competitors have struggled. Activity on our Flex portal has been robust and spans all regions and product grades. Price continues to inflect upward, reflecting stronger demand conditions. As a result of these tighter market dynamics, we continue to sign up new AVA customers who are drawn to the combination of supply reliability, service and quality that only Chemours can provide. These new long-term contracts demonstrate the value of TVS, and are the foundation for deep long-term relationships with these customers. Turning to the numbers. First quarter net sales rose 18% to $723 million. Volume increased 16% versus the prior year. Adjusted EBITDA for the segment rose 22% to $169 million despite the headwinds from the winter storm and logistics issues around the globe. Price was up slightly on a sequential basis despite some customer and product mix drag. As we look ahead, a return to more normalized order patterns and AVA growth in Q1 leads us to believe volumes will be strong throughout the balance of the year. We believe that renovation and remodel trends are strong, with stimulus and infrastructure potentially providing longer-term tailwinds. Over the coming months, we intend to make steady market share gains, with the goal of returning to our capacity share by year-end. Margin should improve as production continues to ramp up across the next several quarters. I am very proud of the resilience that business has shown over the course of the first year of the COVID-19 pandemic and our ability to quickly pivot and adapt to the ever-changing market conditions. Through it all, we have demonstrated the quality and differentiation of the Ti-Pure franchise, setting the stage for significant value creation in the coming years. Moving to Chart 10. In the Thermal & Specialized Solutions, demand signals continued to strengthen in the first quarter, with order patterns reflecting pre-pandemic seasonality. Opteon adoption in the automotive and stationary applications continue as the world recognizes the importance that low global warming refrigerants will play in combating climate change. Looking more closely at the results, Q1 net sales were $304 million, nearly flat from Q1 2020, but up 12% on a sequential basis. Improved adoption rates of Opteon blends and stationary applications were offset by a decline in volumes related to the expected regulatory phaseout of legacy-based refrigerants. While overall demand for Opteon is strong, semiconductor shortages slowed the automotive bill rates in Q1, leading to modest adjustments in customer order patterns. At present, we anticipate a continuation of constrained automotive bill rates in Q2 and through year-end. Segment adjusted EBITDA rose 6% to $93 million in the first quarter. This was the result of improved operating rates at our Corpus Christi facility, which more than offset the $7 million of under-absorbed fixed costs from Winter Storm Uri plant downtime. Looking ahead, I'm confident that we will put the onetime issues from Q1 behind us and are well positioned for a strong Q2 and Q3 as the cooling season gets underway. Auto aftermarket adoption and the market for Opteon stationary blends continues to grow as equipment conversions start to take hold. In Europe, we see a steady cadence of illegal HFC refrigerant seizures through continued enforcement and awareness campaigns behind the F-Gas regulation. In the U.S., we applaud the efforts of EPA and engaged industry stakeholders who have been working with such an aggressive time line to codify standards for HFC transitions. We expect this will accelerate the transition in the stationery market to HFOs behind the recently passed AIM Act. We are mindful of the impact lower automotive bill rates could have on demand for mobile opt-in refrigerants and continue to manage our supply chain in close coordination with our customers. Turning to Chart 11, I'll cover our Advanced Performance Materials segment. The rebound, which started in Q4 2020 continued in Q1 2021. Net sales improved 14% to $333 million, and March was a record month for APM as underlying demand accelerated late in the quarter. The recovery has been broad-based, with demand rising across the breadth of our product mix and across all geographies. Segment adjusted EBITDA was $51 million, flat to last year's first quarter. Margins sequentially rose to 15%, weighed down by higher accruals for incentive composition in the quarter as well as the impact of fixed cost under absorption versus Q1 2020 due to supply chain issues related to Winter Storm Uri. As we said on the fourth quarter call, we have significant operating leverage across the segment. Our results in the first quarter illustrate this potential. On a sequential basis, revenue was up $54 million, resulting in an earnings lift of $26 million. Looking out across the rest of 2021, the outlook remains strong. We remain focused on top line recovery and growth while executing on productivity and cost improvement actions to enhance returns. We believe margins in this business will return to the high teens, starting in the second quarter. APM is prepared to seize the moment. We have already made great strides delivering on our 2020 performance improvement plan with a rapid return to pre-pandemic quarterly sales, reliable plant operations and realizing significant progress towards our high teens EBITDA margin target. Despite this notable improvement, we recognize the importance of defining our post-recovery strategy and better communicating our enthusiasm for the opportunity in this segment. With this in mind, we are planning to host an investor deep dive later this year to unpack the APM segment in a greater level of detail. Moving ahead to our Chemical Solutions segment on Chart 12, and first quarter net sales were $76 million. Excluding the portfolio impact of the shutdown of our aniline business last year, Chemical Solutions sales increased 2% on a year-over-year basis driven by improving demand for sodium cyanide and continued strong demand for Performance Chemicals and Intermediate Products. Adjusted EBITDA was $10 million for the first quarter of 2021, including $2 million impact from freezing conditions at our Memphis facility in February. We anticipate continued momentum in mining solutions, driven by robust demand as conditions in gold mining continue to improve. Glycolic acid demand remains strong and we anticipate a return to more normal adjusted EBITDA margins across the business over the course of 2021. Turning to the next chart. The strength of our Q1 results and the momentum we are seeing in both volume and price across our core markets give us confidence that our 2021 results will be higher than we communicated in our Q4 call. As a result, we are raising our adjusted EBITDA guidance by $100 million to between $1.1 billion and $1.25 billion. Our revised guidance is now up 34% from 2020 levels at the midpoint of $1.175 billion. We continue to drive a disciplined approach to CapEx in 2021 with no change to that metric at approximately $350 million. As a result, our free cash flow guidance is now greater than $450 million, up $100 million from our prior guidance. Our focus on our North Star and cash generation has not waned with a recovery underway. We remain fully committed to generating significant earnings and free cash flow through the cycle and maximizing the value of Chemours long term. With that, I'll turn things back over to Mark Vergnano for some closing thoughts.